Friday, May 8, 2009
Report claims preemption is good for consumers
A new study by two MIT professors concludes that eliminating FDA's preemption protection would decrease patients' access to life-enhancing medical devices, increase health care costs and reduce medical device industry employment. It must be noted, however, that the study was paid for by the Advanced Medical Technology Association (AdvaMed), the leading trade organization for the medical device industry - the industry that stands to lose the most if Congress passes legislation eliminating preemption in these types of cases. A summary of the study is available here. PopTort blog has a comment on this here.